Company intelligence / Profile preview
HEMA Biologics
Louisville, Kentucky, United Stateshemabio.com ↗
- Ownership
- Private
- Employees
- ~27
- Development stage
- Commercial
01
Overview
HEMA Biologics has achieved FDA approval for SEVENFACT® [coagulation factor VIIa (recombinant)-jncw], a treatment for hemophilia A or B with inhibitors. The company is focused on rare bleeding disorders and aims to bring innovative therapies to the U.S. market, leveraging both plasma-based and recombinant technologies from its manufacturing partner LFB.[3][4][5] No additional clinical results are detailed in the available sources.
- Therapeutic areas
- Hematology
- Modalities
- Recombinant proteins (notably recombinant coagulation factors)[5]Plasma-derived products[4]
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
LFB (global leader in plasma-based products and recombinant technology, manufacturer of HEMA’s products)[4]
Beyond the preview
Go deeper on HEMA Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HEMA Biologics.